Monitoring drug adherence

Transplantation Reviews

Volumn 29, Issue 2, 2015, Pages 73-77

  Lieber, Sarah R ^a   Helcer, Jacqueline ^a,b,c   Shemesh, Eyal ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b FORDHAM UNIVERSITY   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR MODIFICATION; COGNITIVE THERAPY; DRUG MONITORING; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; MEASUREMENT; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT EDUCATION; REVIEW; RISK FACTOR; TREATMENT REFUSAL; BEHAVIOR THERAPY; GRAFT REJECTION;

IMMUNOSUPPRESSIVE AGENT;

BEHAVIOR THERAPY; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; RISK FACTORS;

EID: 84928110381     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.10.001     Document Type: Review

References (79)

1. Cromer B.A., Tarnowski K.J. Noncompliance in adolescents: a review. J Dev Behav Pediatr 1989, 10:207-215.
2. De Geest S., Moons P., Dobbels F., et al. Profiles of patients who experienced a late acute rejection due to nonadherence with immunosuppressive therapy. J Cardiovasc Nurs 2001, 16:1-14.
3. Dew M.A., Kormos R.L., Roth L.H., et al. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant 1999, 18:549-562.
4. Didlake R.H., Dreyfus K., Kerman R.H., et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988, 20:63-69.
5. McDermott M.M., Schmitt B., Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. A critical review. Arch Intern Med 1997, 157:1921-1929.
6. Milgrom H., Bender B. Nonadherence to asthma treatment and failure of therapy. Curr Opin Pediatr 1997, 9:590-595.
7. Murri R., Ammassari A., De Luca A., et al. Self-reported nonadherence with antiretroviral drugs predicts persistent condition. HIV Clin Trials 2001, 2:323-329.
8. Chisholm-Burns M.A., Spivey C.A. The 'cost' of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc (2003) 2012, 52:823-826.
9. Kerkar N., Annunziato R., Foley L., et al. Prospective analysis of non-adherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006, 43:629-634.
10. Ringewald J.M., Gidding S.S., Crawford S.E., et al. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr 2001, 139:75-78.
11. Molmenti E., Mazariegos G., Bueno J., et al. Noncompliance after pediatric liver transplantation. Transplant Proc 1999, 31:408.
12. Garcia V., Bittar A., Keitel E., et al. Patient noncompliance as a major cause of kidney graft failure. Transplant Proc 1997, 29:252-254.
13. Lurie S., Shemesh E., Sheiner P.A., et al. Non-adherence in pediatric liver transplant recipients-an assessment of risk factors and natural history. Pediatr Transplant 2000, 4:200-206.
14. Chisholm M.A., Lance C.E., Williamson G.M., Mulloy L.L. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns 2005, 59:13-20.
15. Denhaerynck K., Dobbels F., Cleemput I., et al. Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Trans Int 2005, 18:1121-1133.
16. Fine R.N., Becker Y., De Geest S., et al. Nonadherence consensus conference summary report. Am J Transplant 2009, 9:35-41.
17. Butler J.A., Peveler R.C., Roderick P., Horne R., Mason J.C. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004, 77:786-789.
18. Shemesh E. Measuring adherence to medications: are complex methods superior to simple ones?. Pediatr Transplant 2012, 16:315-317.
19. Shemesh E., Fine R.N. Is calculating the standard deviation of tacrolimus blood levels the new gold standard for evaluating non-adherence to medications in transplant recipients?. Pediatr Transplant 2010, 14:940-943.
20. Johnson S.B. Measuring adherence. Diabetes Care 1992, 15:1658-1667.
21. Shemesh E. Adherence to medical regimens. Walker's pediatric gastrointestinal disease 2008, vol. 2:1497-1503. BC Decker Inc., Ontario, Canada, [chapter 56]. 5th ed. R.E. Kleinman, O.J. Goulet, G. Mieli-Vergani, I.R. Sanderson, P.M. Sherman, B.L. Shneider (Eds.).
22. Eisenberger U., Wüthrich R.P., Bock A., et al. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation 2013, 96:245-250.
23. Macready N. Adherence efforts go high-tech. Am J Transplant 2012, 12:2263-2264.
24. De Bleser L., DE Geest S., Vincke B., Ruppar T., Vanhaecke J., Dobbels F. How to test electronic adherence monitoring devices for use in daily life: a conceptual framework. Comput Inform Nurs 2011, 29:489-495.
25. Lieber S.R., Volk M.L. Non-adherence and graft failure in adult liver transplant recipients. Dig Dis Sci 2013, 58:824-834.
26. Supelana C., Annunziato R., Schiano T., Anand R., Vaidya S., Chuang K., Zack Y., Florman S., Shneider B.L., Shemesh E. The medication level variability index (MLVI) predicts rejection, possibly due to nonadherence, in adult liver transplant recipients. Liver Transpl 2014 Oct, 20(10):1168-1177.
27. Dew M.A., Dabbs A.D., Myaskovsky L., et al. Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 2009, 88:736-746.
28. Schafer-Keller P., Steiger J., Bock A., Denhaerynck K., De Geest S. Diagnostic accuracy of measurement methods to assess nonadherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant 2008, 8:616-626.
29. Shemesh E., Shneider B.L., Savitzky J.K., et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004, 113:825-832.
30. Burney K.D., Krishnan K., Ruffin M.T., et al. Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med 1996, 5:297-300.
31. Waterhouse D.M., Calzone K.A., Mele C., Brenner D.E. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993, 11:1189-1197.
32. Bender B., Wamboldt F.S., O'Connor S.L., et al. Measurement of children's asthma medication adherence by self report, mother report, canister weight, and Doser CT. Ann Allergy Asthma Immunol 2000, 85:416-421.
33. Inui T.S., Carter W.B., Pecoraro R.E. Screening for noncompliance among patients with hypertension: is self-report the best available measure?. Med Care 1981, 19:1061-1064.
34. Ley P. Doctor-patient communication: some quantitative estimates of the role of cognitive factors in non-compliance. J Hypertens Suppl 1985, 3:S51-S55.
35. Salas M., In't Veld B.A., van der Linden P.D., et al. Impaired cognitive function and compliance with antihypertensive drugs in elderly: the Rotterdam Study. Clin Pharmacol Ther 2001, 70:561-566.
36. Hinkin C.H., Castellon S.A., Durvasula R.S., et al. Medication adherence among HIV+adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59:1944-1950.
37. Kieckhefer G.M., Trahms C.M. Supporting development of children with chronic conditions: from compliance toward shared management. Pediatr Nurs 2000, 26:354-363.
38. Stone V.E., Hogan J.W., Schuman P., et al. Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the her study. J Acquir Immune Defic Syndr 2001, 28:124-131.
39. Schmier J.K., Leidy N.K. The complexity of treatment adherence in adults with asthma: challenges and opportunities. J Asthma 1998, 35:455-472.
40. Ammassari A., Murri R., Pezzotti P., et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr 2001, 28:445-449.
41. Hamano K., Ohta A., Masamura K., et al. Relationship between the experience of steroids side effects and noncompliance with oral steroids treatment in collagen disease patients. Kango Kenkyu 1997, 30:47-54.
42. Bjorn I., Backsrom T. Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas 1999, 32:77-86.
43. Richardson J.L., Marks G., Levine A. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol 1988, 6:1746-1752.
44. Hyder S.M., Persson L.A., Chowdhury A.M., Ekstrom E.C. Do side-effects reduce compliance to iron supplementation? A study of daily- and weekly-dose regimens in pregnancy. J Health Popul Nutr 2002, 20:175-179.
45. Hsia J., Rodabough R., Rosal M.C., et al. Compliance with National Cholesterol Education Program dietary and lifestyle guidelines among older women with self-reported hypercholesterolemia. The Women's Health Initiative. Am J Med 2002, 113:384-392.
46. Chisholm-Burns M., Pinsky B., Parker G., et al. Factors related to immunosuppressant medication adherence in renal transplant recipients. Clin Transplant 2012, 26:706-713.
47. O'Carroll R.E., McGregor L.M., Swanson V., Masterton G., Hayes P.C. Adherence to medication after liver transplantation in Scotland: a pilot study. Liver Transpl 2006, 12:1862-1868.
48. Shemesh E., Lurie S., Stuber M.L., et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 2000, 105:E29.
49. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
50. Lernmark B., Persson B., Fisher L., Rydelius P.A. Symptoms of depression are important to psychological adaptation and metabolic control in children with diabetes mellitus. Diabet Med 1999, 16:14-22.
51. DeGroot M., Jacobson A.M., Samson J.A., Welch G. Glycemic control and major depression in patients with type I and type II diabetes mellitus. J Psychosom Res 1999, 46:425-435.
52. Shemesh E., Rudnick A., Kaluski E., et al. A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction. Gen Hosp Psychiatry 2001, 23:215-222.
53. Dew M.A., Roth L.H., Thompson M.E., et al. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant 1996, 15:631-645.
54. Raiz L.R., Kilty K.M., Henry M.L., Ferguson R.M. Medication compliance following renal transplantation. Transplantation 1999, 68:51-55.
55. Wilson B.M. Promoting compliance: the patient-provider partnership. Adv Ren Replace Ther 1995, 2:199-206.
56. Reynaert C., Janne P., Donckier J., et al. Locus of control and metabolic control. Diabete Metab 1995, 21:180-187.
57. Rorer B., Tucker C.M., Blake H. Long-term nurse-patient interactions: factors in patient compliance or noncompliance to the dietary regimen. Health Psychol 1988, 7:35-46.
58. Katz R.C., Ashmore J., Barboa E., et al. Knowledge of disease and dietary compliance in patients with end-stage renal disease. Psychol Rep 1998, 82:331-336.
59. Abercrombie P.D. Improving adherence to abnormal Pap smear follow-up. J Obstet Gynecol Neonatal Nurs 2001, 30:80-88.
60. Kelly D.A., Bucuvalas J.C., Alonso E.M., et al. Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013, 19:798-825.
61. Demonceau J., Ruppar T., Kristanto P., et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 2013, 73:545-562.
62. Molloy G.J., O'Carroll R.E., Witham M.D., McMurdo M.E. Interventions to enhance adherence to medications in patients with heart failure: a systematic review. Circ Heart Fail 2012, 5:126-133.
63. Chisholm-Burns M.A., Spivey C.A., Graff Zivin J., Lee J.K., Sredzinski E., Tolley E.A. Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant 2013, 13:2364-2373.
64. Powell L.H., Calvin J.E., Richardson D., et al. Self-management counseling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial. JAMA 2010, 304:1331-1338.
65. Berben L., Bogert L., Leventhal M.E., et al. Which interventions are used by health care professionals to enhance medication adherence in cardiovascular patients? A survey of current clinical practice. Eur J Cardiovasc Nurs 2011, 10:14-21. [Epub 2010 Nov 20].
66. Thompson D.R., Chair S.Y., Chan S.W., Astin F., Davidson P.M., Ski C.F. Motivational interviewing: a useful approach to improving cardiovascular health?. J Clin Nurs 2011, 20:1236-1244.
67. Choudhry N.K., Avorn J., Glynn R.J., et al. Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011, 365:2088-2097.
68. Brown T.M., Siu K., Walker D., Pladevall-Vila M., Sander S., Mordin M. Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. J Manag Care Pharm 2012, 18:351-362.
69. Kugler C., Geyer S., Gottlieb J., Simon A., Haverich A., Dracup K. Symptom experience after solid organ transplantation. J Psychosom Res 2009, 66:101-110.
70. Topinková E., Baeyens J.P., Michel J.P., Lang P.O. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012, 29:477-494.
71. Low J.K., Williams A., Manias E., Crawford K. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrol Dial Transplant 2014, [Epub ahead of print].
72. Dunbar-Jacob J., Erlen J.A., Schlenk E.A., et al. Adherence in chronic disease. Annu Rev Nurs Res 2000, 18:48-90.
73. Annunziato R.A., Baisley M.C., Arrato N., et al. Strangers headed to a strange land? A pilot study of using a transition coordinator to improve transfer from pediatric to adult services. J Pediatr 2013, 163:1628-1633. [Epub 2013 Aug 29]. 10.1016/j.jpeds.2013.07.031.
74. Hare J., Clark-Carter D., Forshaw M. A randomized controlled trial to evaluate the effectiveness of a cognitive behavioural group approach to improve patient adherence to peritoneal dialysis fluid restrictions: a pilot study. Nephrol Dial Transplant 2014, 29:555-564.
75. Sin N.L., DiMatteo M.R. Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis. Ann Behav Med 2014, 47:259-269.
76. Shemesh E., Stuber M.L. Posttraumatic stress disorder in medically ill patients: what is known, what needs to be determined, and why is it important?. CNS Spectr 2006, 11:106-117.
77. Dale S., Cohen M., Weber K., Cruise R., Kelso G., Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS 2014, 28:136-143.
78. Adherence to long-term therapies: evidence for action 2003, World Health Organization.
79. Levy R.L., Feld A.D. Increasing patient adherence to gastroenterology treatment and prevention regimens. Am J Gastroenterol 1999, 94:1733-1742.